跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,805 条关于
“Curium Pharma”
全部
9,805
临床试验
4,202
药物
1,138
机构
1,245
资讯
3,220
8个月前
Curium Receives Chinese Regulatory Approval to Begin Phase 3 Trial of 177Lu-PSMA-I&T for Metastatic Prostate Cancer
4个月前
Curium Knocks Out Novartis Cancer Drug Patents in Generics Fight
去年
EMA Issues Strategic Recommendations to Address Critical Radiopharmaceutical Supply Chain Vulnerabilities in Europe
去年
Curium Expands European Nuclear Medicine Footprint with Strategic Acquisitions of Nucleis and Monrol
去年
Curium Completes Enrollment of Phase 3 SOLAR-RECUR Prostate Cancer Trial
11个月前
PeptiDream, PDRadiopharma and Curium Initiate Registrational Trial for 64Cu-PSMA-I&T in Japanese Prostate Cancer Patients
前天
FDA Approves Bexlutry, First Generic Radioligand Therapy, After Curium Wins Novartis Patent Dispute
去年
Curium and PDRadiopharma Collaborate to Advance PSMA-Targeting Theranostics in Japan
3个月前
Curium, PeptiDream and PDRadiopharma Complete Patient Dosing in Phase 2 Trial of 64Cu-PSMA-I&T PET Diagnostic for Prostate Cancer in Japan
3个月前
Delaware Court Clears Path for Curium's Lutetium Lu 177 Dotatate in GEP-NETs, Invalidating Novartis Patents
第 1 页,共 322 页
上一页
下一页